465 GEM-3: phase 3 safety and immunogenicity results of beremagene geperpavec (B-VEC), an investigational, topical gene therapy for dystrophic epidermolysis bullosa (DEB) von Marinkovich, M., Gonzalez, M., Guide, S., Bagci, I.S., Chitra, S., Agostini, B., Chen, H., Parry, T., Krishnan, S.

Volltext

306 Topical QR-313, an Antisense Oligonucleotide, in the Treatment of Dystrophic Epidermolysis Bullosa von Marinkovich, M.P., Sridhar, K., Karkala, V., Yenamandra, V.K., Gurevitch, I., Dolorito, J., Bagci, I.S., O'Mara, C., Ramsdell, D., Landy, H.

Volltext

286 Diagnostic value of linear fluorescence of the basement membrane of sweat ducts von Bagci, I.S., Horváth, O., Ruzicka, T., Sárdy, M.

Volltext

175 Effects of short-term moisturizer application in different ethnic skin types - non-invasive assessment with optical coherence tomography and reflectance confocal microscopy von Bagci, I.S., Ruini, C., Niesert, A., Horváth, O., Berking, C., Ruzicka, T., von Braunmühl, T.

Volltext

Ex vivo confocal laser scanning microscopy for bullous pemphigoid diagnostics: new era in direct immunofluorescence? von Bağcı, I.S., Aoki, R., Krammer, S., Ruzicka, T., Sárdy, M., French, L.E., Hartmann, D.

Volltext